Thursday, April 2, 2020

Thursday, April 2, 2020

5 drugs recalled during May, FDA reports

Five drugs were recalled in May to protect patients from possible harmful defects associated with the products, the U.S. Food and Drug Administration reported.

Such recalls are voluntary actions carried out by drug makers to remove potentially defective medicines from the market, the FDA said. They may be initiated either by the manufacturer or the FDA.


Drug Recalls for May

DateBrand NameProduct DescriptionReason/ ProblemCompany
May 29Pecgen DMX,PECGEN DMX, 16 oz., liquid cough syrupMislabelingNOVIS PR LLC
May 28HeritageAmikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL)Potential Lack of SterilityHeritage Pharmaceuticals Inc.
May 11PromactaPromacta 12.5 mg oral suspensionPotential Foreign MaterialNovartis
May 3HeritageLosartan Potassium Tablets USPDefectVivimed
May 1 Par PharmaceuticalMycophenolate Mofetil for injectionPotential Foreign MaterialPar Pharmaceutical Inc.
Source: U.S. Food and Drug Administration

Organizations in this Story

U.S. Food and Drug Administration (FDA)

More News

FDA Health News